Evidence has shown that mutations of B-raf protooncogene-serine/threonine kinase (BRAF) in the mitogen-activated protein kinase pathway play important roles in the progression of LCH, although its pathogenesis is not fully understood [5]. Here, BRAF is linked to Langerhans cell histiocytosis.